Hacıoğlu MB - Search Results

1

Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma.

Küçükarda A, Erdoğan B, Gökyer A, Sayın S, Gökmen İ, Özcan E, Hacıoğlu MB, Uzunoğlu S, Çiçin İ. Küçükarda A, et al. Among authors: hacioglu mb. Support Care Cancer. 2022 Mar;30(3):2131-2139. doi: 10.1007/s00520-021-06627-6. Epub 2021 Oct 22. Support Care Cancer. 2022. PMID: 34677649

2

Clinical features of the patient with multiple primary tumors: Single center experience.

Gokyer A, Kostek O, Hacioglu MB, Erdogan B, Kodaz H, Turkmen E, Hacibekiroglu I, Uzunoglu S, Cicin I. Gokyer A, et al. Among authors: hacioglu mb. North Clin Istanb. 2017 May 10;4(1):43-51. doi: 10.14744/nci.2017.67044. eCollection 2017. North Clin Istanb. 2017. PMID: 28752142 Free PMC article.

3

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

Köstek O, Hacıoğlu MB, Sakin A, Demir T, Sarı M, Ozkul O, Araz M, Doğan AF, Demircan NC, Uzunoğlu S, Çiçin İ, Erdoğan B. Köstek O, et al. Among authors: hacioglu mb. Cancer Chemother Pharmacol. 2019 Jan;83(1):115-122. doi: 10.1007/s00280-018-3713-6. Epub 2018 Oct 29. Cancer Chemother Pharmacol. 2019. PMID: 30374523

4

Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer.

Köstek O, Yılmaz E, Hacıoğlu MB, Demircan NC, Gökyer A, Uzunoğlu S, Tunçbilek N, Çiçin İ, Erdoğan B. Köstek O, et al. Among authors: hacioglu mb. Cancer Chemother Pharmacol. 2019 Apr;83(4):735-742. doi: 10.1007/s00280-019-03779-5. Epub 2019 Jan 24. Cancer Chemother Pharmacol. 2019. PMID: 30680522

5

Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib.

Gökyer A, Küçükarda A, Köstek O, Hacıoğlu MB, Sunal BS, Demircan NC, Uzunoğlu S, Solak S, İşsever K, Çiçin I, Erdoğan B. Gökyer A, et al. Among authors: hacioglu mb. Clin Transl Oncol. 2019 Nov;21(11):1518-1523. doi: 10.1007/s12094-019-02080-4. Epub 2019 Mar 13. Clin Transl Oncol. 2019. PMID: 30868388

6

Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer.

Köstek O, Demircan NC, Gökyer A, Küçükarda A, Sunal BS, Hacıoğlu MB, Eslame H, Solak S, Yılmaz E, Uzunoğlu S, Tunçbilek N, Çiçin I, Erdoğan B. Köstek O, et al. Among authors: hacioglu mb. Clin Transl Oncol. 2019 Nov;21(11):1510-1517. doi: 10.1007/s12094-019-02079-x. Epub 2019 Mar 28. Clin Transl Oncol. 2019. PMID: 30924091

7

Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?

Köstek O, Bozkaya Y, Hacıoğlu MB, Yıldırım Özdemir N, Yılmaz E, Demircan NC, Erdoğan B, Uzunoğlu S, Çiçin İ, Zengin N. Köstek O, et al. Among authors: hacioglu mb. Arch Iran Med. 2019 May 1;22(5):236-241. Arch Iran Med. 2019. PMID: 31256595

8

Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study.

Gökyer A, Küçükarda A, Köstek O, Hacıoğlu MB, Uzunoğlu S, Kula O, Kurt N, Üstündağ S, Erdoğan B, Çiçin İ. Gökyer A, et al. Among authors: hacioglu mb. Int J Clin Oncol. 2020 Oct;25(10):1757-1762. doi: 10.1007/s10147-020-01729-3. Epub 2020 Jun 26. Int J Clin Oncol. 2020. PMID: 32591963

9

The relationship between FDG PET/CT-defined metabolic parameters and the histopathological subtype of oesophageal carcinomas.

Korkmaz U, Hacioglu MB, Kostek O, Sut N, Kodaz H, Erdogan B, Ustun F, Saynak M, Tastekin E, Cicin I, Durmus-Altun G. Korkmaz U, et al. Among authors: hacioglu mb. Pol J Radiol. 2020 May 15;85:e254-e260. doi: 10.5114/pjr.2020.95945. eCollection 2020. Pol J Radiol. 2020. PMID: 32612724 Free PMC article.

10

Prognostic Factors for Survival in Transverse Colon Cancers.

Küçükarda A, Gökyer A, Sayın S, Gökmen İ, Özcan E, Köstek O, Hacıoğlu MB, Uzunoğlu S, Çiçin İ, Erdoğan B. Küçükarda A, et al. Among authors: hacioglu mb. J Gastrointest Cancer. 2022 Mar;53(1):31-40. doi: 10.1007/s12029-021-00675-1. Epub 2021 Jul 24. J Gastrointest Cancer. 2022. PMID: 34302255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters